(Q50491281)

English

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.

scientific article published on 7 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

based on heuristic

inferred from title

Jens Juul Holst

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Patrick Schrauwen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

E Konings

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

S Timmers

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E E Blaak

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

7 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1214-1218

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23663119%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Plant foods and herbal sources of resveratrol

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Resveratrol, obesity and diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Pilot study of resveratrol in older adults with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Insulin secretion and cyclooxygenase enzyme inhibition by cabernet sauvignon grape skin compounds

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

The alpha-cell as target for type 2 diabetes therapy.

1 reference

https://api.crossref.org/works/10.1111%2FDME.12231

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50491281&oldid=1514172915"